Company Overview and News

 
Argent Minerals enters new growth phase with board changes

7h proactiveinvestors.com.au
Argent Minerals Ltd (ASX:ARD) has welcomed some board changes to facilitate a new growth phase for the company.
Upvote Downvote

 
Argent Minerals achieves valuable milestone with metallurgical test work results

2018-04-12 proactiveinvestors.com.au
Argent Minerals Ltd (ASX:ARD) has shown with metallurgical test work that primary material from its Kempfield Polymetallic Project in New South Wales can be successfully separated.
Upvote Downvote

 
Argent Minerals gets more cash to advance projects in New South Wales

2017-12-14 proactiveinvestors.com.au
Argent Minerals Limited (ASX:ARD) has received $693,748 in relation to its research and development (R&D) claim for the financial year ending 30 June 2017.
Upvote Downvote

 
Argent Minerals secures funds for gold, silver, lead and zinc exploration

2017-12-13 proactiveinvestors.com.au
Argent Minerals Limited (ASX:ARD) has secured $1.2 million in a private placement to advance its top three precious and base metals projects all in New South Wales.
Upvote Downvote

 
Argent Minerals to open capital raising following enhanced potential at Kempfield

2017-12-12 proactiveinvestors.com.au
Argent Minerals Ltd (ASX:ARD) recent metallurgical test work further enhanced the potential of the Kempfield project in New South Wales.
Upvote Downvote

 
Argent Minerals' metallurgical test work enhances recoverable metal from Kempfield

2017-11-12 proactiveinvestors.com.au
Argent Minerals Ltd (ASX:ARD) has further enhanced the potential of the Kempfield project in New South Wales.
Upvote Downvote

 
Argent Minerals reveals unprecedented scale potential for Kempfield

2017-11-08 proactiveinvestors.com.au
Argent Minerals Limited (ASX:ARD) has now revealed further upside and potential scalability for its Kempfield project in New South Wales.
Upvote Downvote

 
Argent Minerals reveals copper-gold porphyry potential at Loch Lilly

2017-11-04 proactiveinvestors.com.au
Argent Minerals Ltd (ASX:ARD) has a portfolio of three potential company making projects, and all three have been awarded merit-based New South Wales Government funding.
Upvote Downvote

 
Argent Minerals advances three projects in tandem as news flow set to increase

2017-08-18 proactiveinvestors.com.au
Argent Minerals Ltd (ASX:ARD) has a portfolio of three highly prospective projects which have all been awarded merit-based new South Wales Government funding.
Upvote Downvote

 
Argent Minerals' David Busch discusses next exploration steps at Proactive's CEO Sessions

2017-07-27 proactiveinvestors.com.au
Argent Minerals' (ASX:ARD) managing director, David Busch, joined Proactive's CEO Sessions in Melbourne on Tuesday 25th July.
Upvote Downvote

 
Argent Minerals assays copper and gold in suspected porphyry

2017-07-27 proactiveinvestors.com.au
Argent Minerals (ASX:ARD) has received assays from its final two diamond drill holes of a six hole program at its West Wyalong Project in New South Wales.
Upvote Downvote

 
Argent Minerals underway drilling at Loch Lilly

2017-07-24 proactiveinvestors.com.au
Argent Minerals (ASX:AGY) has commenced diamond drilling at its Loch Lilly Joint Venture Project located in western New South Wales.
Upvote Downvote

 
Argent Minerals underway drilling at Loch Lilly

2017-07-24 proactiveinvestors.com.au
Argent Minerals (ASX:AGY) has commenced diamond drilling at its Loch Lilly Joint Venture Project located in western New South Wales.
Upvote Downvote

 
Argent Minerals brings latest from West Wyalong and Kempfield to Melbourne CEO Sessions

2017-07-21 proactiveinvestors.com.au
Argent Minerals Ltd's (ASX:ARD) CEO, David Busch, will be bringing the company's three-pronged project strategy to the Melbourne leg of Proactive's CEO Sessions.
Upvote Downvote

 
Argent Minerals Ltd once again lifts potential of copper-gold-molybdenum porphyry

2017-07-17 proactiveinvestors.com.au
Argent Minerals Ltd's (ASX:ARD) shares are trading 6.7% higher at $0.032 in afternoon trade following the company revealing assay results from the recently completed West Wyalong diamond drilling program.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...